943133-81-1 Usage
General Description
ZP 1609 Hydrochloride is a chemical compound that is commonly used in research and biochemistry studies. It is a selective dopamine D1 receptor antagonist, meaning it blocks the activity of these receptors in the brain. ZP 1609 Hydrochloride is often used in experiments to study the role of dopamine D1 receptors in various physiological and pathological conditions, such as drug addiction, schizophrenia, and Parkinson's disease. ZP 1609 Hydrochloride is also being investigated for its potential therapeutic applications in these and other neurological disorders. Overall, this compound is an important tool in the study of dopamine receptor biology and has the potential to contribute to the development of new treatments for a range of neurological conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 943133-81-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,1,3 and 3 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 943133-81:
(8*9)+(7*4)+(6*3)+(5*1)+(4*3)+(3*3)+(2*8)+(1*1)=161
161 % 10 = 1
So 943133-81-1 is a valid CAS Registry Number.
943133-81-1Relevant articles and documents
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation
Butera, John A.,Larsen, Bjarne Due,Herman, James K.,Kerns, Edward,Di, Li,Alimardanov, Asaf,Swillo, Robert E.,Morgan, Gwen A.,Liu, Kun,Wang, Qiang,Rossman, Eric I.,Unwalla, Rayomand,McDonald, Leonard,Huselton, Christine,Petersen, J?rgen S.
, p. 908 - 911 (2009)
Rotigaptide (3) is an antiarrhythmic peptide that improves cardiac conduction by modifying gap-junction communication. Small molecule gap-junction modifiers with improved physical properties were identified from a Zealand Pharma peptide library using phar
Modified lysine-mimetic compounds
-
Page/Page column 35, (2008/06/13)
Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
